4. Jefferson T, Del Mar CB, Dooley L, Ferroni E, Al-Ansary LA, Bawazeer GA, et al. 2011; Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database Syst Rev. 2011:CD006207. DOI:
10.1002/14651858.CD006207.pub4. PMID:
21735402. PMCID:
PMC6993921.
Article
5. Ahmed F, Zviedrite N, Uzicanin A. 2018; Effectiveness of workplace social distancing measures in reducing influenza transmission: a systematic review. BMC Public Health. 18:518. DOI:
10.1186/s12889-018-5446-1. PMID:
29669545. PMCID:
PMC5907354.
Article
6. Ujiie M, Tsuzuki S, Nakamoto T, Iwamoto N. 2021; Resurgence of respiratory syncytial virus infections during COVID-19 pandemic, Tokyo, Japan. Emerg Infect Dis. 27:2969–70. DOI:
10.3201/eid2711.211565. PMID:
34388086. PMCID:
PMC8544984.
Article
7. Lee SJ, Lee SH, Ha EK, Sheen YH, Sung MS, Jung YH, et al. 2017; Prevalence of respiratory virus infection with regard to age, sex, and seasonality factors: a single center experience against children hospitalized during the 10 years. Allergy Asthma Resp Dis. 5:320–5. DOI:
10.4168/aard.2017.5.6.320.
Article
8. Park JY, Kim HI, Kim JH, Park S, Hwang YI, Jang SH, et al. 2021; Changes in respiratory virus infection trends during the COVID-19 pandemic in South Korea: the effectiveness of public health measures. Korean J Intern Med. 36:1157–68. DOI:
10.3904/kjim.2021.026. PMID:
34399570. PMCID:
PMC8435496.
Article